Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Theuns

Showing results (161-170 of 173) with videos related to

Pageof 18
Sort By:
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|February 9, 2012
Psychosocial impact of implantable cardioverter defibrillators (ICD) in young adults with Tetralogy of FallotPetra Opić, Elisabeth M W J Utens, Philip Moons, et al.
International Journal of Cardiology|June 1, 2015
Inappropriate shocks in the subcutaneous ICD: Incidence, predictors and managementLouise R A Olde Nordkamp, Tom F Brouwer, Craig Barr, et al.
European Journal of Heart Failure|August 11, 2004
Guiding and optimization of resynchronization therapy with dynamic three-dimensional echocardiography and segmental volume--time curves: a feasibility studyBoudewijn J Krenning, Tamas Szili-Torok, Marco M Voormolen, et al.
Psychosomatic Medicine|September 30, 2014
E-health to manage distress in patients with an implantable cardioverter-defibrillator: primary results of the WEBCARE trialMirela Habibović, Johan Denollet, Pim Cuijpers, et al.
Journal of the American College of Cardiology|April 25, 2015
Safety and Efficacy of the Totally Subcutaneous Implantable Defibrillator: 2-Year Results From a Pooled Analysis of the IDE Study and EFFORTLESS RegistryMartin C Burke, Michael R Gold, Bradley P Knight, et al.
Journal of the American College of Cardiology|October 16, 2012
The entirely subcutaneous implantable cardioverter-defibrillator: initial clinical experience in a large Dutch cohortLouise R A Olde Nordkamp, Lara Dabiri Abkenari, Lucas V A Boersma, et al.
ESC Heart Failure|June 29, 2021
Sex-specific differences in outcome and risk stratification of ventricular arrhythmias in implantable cardioverter defibrillator patientsAnne-Lotte C J van der Lingen, Dominic A M J Theuns, Mischa T Rijnierse, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|November 26, 2022
Hospital utilisation and the costs associated with complications of ICD implantation in a contemporary primary prevention cohortM van Barreveld, T E Verstraelen, E Buskens, et al.
Journal of the American Heart Association|March 31, 2021
Dutch Outcome in Implantable Cardioverter-Defibrillator Therapy: Implantable Cardioverter-Defibrillator-Related Complications in a Contemporary Primary Prevention CohortMarit van Barreveld, Tom E Verstraelen, Pascal F H M van Dessel, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|June 10, 2025
Changes in numbers needed to treat and hospital care expenditures of optimized indications for primary prevention implantable cardioverter defibrillators: a scenario analysisM van Barreveld, P F H M van Dessel, E Buskens, et al.
Pageof 18

Showing results (161-170 of 173) with videos related to

Sort By:
Pageof 18
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|February 9, 2012
Psychosocial impact of implantable cardioverter defibrillators (ICD) in young adults with Tetralogy of FallotPetra Opić, Elisabeth M W J Utens, Philip Moons, et al.
International Journal of Cardiology|June 1, 2015
Inappropriate shocks in the subcutaneous ICD: Incidence, predictors and managementLouise R A Olde Nordkamp, Tom F Brouwer, Craig Barr, et al.
European Journal of Heart Failure|August 11, 2004
Guiding and optimization of resynchronization therapy with dynamic three-dimensional echocardiography and segmental volume--time curves: a feasibility studyBoudewijn J Krenning, Tamas Szili-Torok, Marco M Voormolen, et al.
Psychosomatic Medicine|September 30, 2014
E-health to manage distress in patients with an implantable cardioverter-defibrillator: primary results of the WEBCARE trialMirela Habibović, Johan Denollet, Pim Cuijpers, et al.
Journal of the American College of Cardiology|April 25, 2015
Safety and Efficacy of the Totally Subcutaneous Implantable Defibrillator: 2-Year Results From a Pooled Analysis of the IDE Study and EFFORTLESS RegistryMartin C Burke, Michael R Gold, Bradley P Knight, et al.
Journal of the American College of Cardiology|October 16, 2012
The entirely subcutaneous implantable cardioverter-defibrillator: initial clinical experience in a large Dutch cohortLouise R A Olde Nordkamp, Lara Dabiri Abkenari, Lucas V A Boersma, et al.
ESC Heart Failure|June 29, 2021
Sex-specific differences in outcome and risk stratification of ventricular arrhythmias in implantable cardioverter defibrillator patientsAnne-Lotte C J van der Lingen, Dominic A M J Theuns, Mischa T Rijnierse, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|November 26, 2022
Hospital utilisation and the costs associated with complications of ICD implantation in a contemporary primary prevention cohortM van Barreveld, T E Verstraelen, E Buskens, et al.
Journal of the American Heart Association|March 31, 2021
Dutch Outcome in Implantable Cardioverter-Defibrillator Therapy: Implantable Cardioverter-Defibrillator-Related Complications in a Contemporary Primary Prevention CohortMarit van Barreveld, Tom E Verstraelen, Pascal F H M van Dessel, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|June 10, 2025
Changes in numbers needed to treat and hospital care expenditures of optimized indications for primary prevention implantable cardioverter defibrillators: a scenario analysisM van Barreveld, P F H M van Dessel, E Buskens, et al.
Pageof 18